Neil Chatterji

Stock Analyst at B. Riley Securities

(0.25)
# 2476
Out of 5,327 analysts
24
Total ratings
30.77%
Success rate
-3.82%
Average return
12 Stocks
Name Action PT Current % Upside Ratings Updated
CLPT ClearPoint Neuro
Maintains: Strong Buy
15 20
14.69 36.15% 2 Jan 28, 2025
OPRX OptimizeRx
Maintains: Buy
17 13
8.66 50.12% 3 Dec 24, 2024
AUGX Augmedix
Reinstates: Buy
6
n/a n/a 3 Apr 3, 2024
ESTA Establishment Labs H...
Maintains: Buy
95 50
30.02 66.56% 2 Nov 9, 2023
SILK Silk Road Medical
Downgrades: Neutral
54 14
n/a n/a 3 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8
1.58 374.68% 1 Oct 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
15 18
11.88 51.52% 2 Sep 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
2.5 80% 1 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
0.76 360.53% 3 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
1.98 177.78% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
n/a n/a 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.42 292.56% 1 Oct 4, 2022